0001127602-13-033700.txt : 20131204 0001127602-13-033700.hdr.sgml : 20131204 20131204162838 ACCESSION NUMBER: 0001127602-13-033700 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131202 FILED AS OF DATE: 20131204 DATE AS OF CHANGE: 20131204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 OAK PARK DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-5000 MAIL ADDRESS: STREET 1: 9 OAK PARK DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIAMOS CHARLES T CENTRAL INDEX KEY: 0001181286 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 131257618 MAIL ADDRESS: STREET 1: 1360 SOUTH LOOP ROAD CITY: ALAMEDA STATE: CA ZIP: 94502 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-12-02 0001145197 INSULET CORP PODD 0001181286 LIAMOS CHARLES T C/O INSULET CORPORATION 9 OAK PARK DRIVE BEDFORD MA 01730 1 1 Chief Operating Officer Common Stock 2013-12-02 4 M 0 19035 4.86 A 137229 D Common Stock 2013-12-02 4 M 0 3810 18.75 A 141039 D Common Stock 2013-12-02 4 M 0 8000 7.06 A 149039 D Common Stock 2013-12-02 4 M 0 4000 14.48 A 153039 D Common Stock 2013-12-02 4 M 0 27363 15.82 A 180402 D Common Stock 2013-12-02 4 S 0 62208 36.2619 D 118194 D Common Stock 2013-12-03 4 M 0 1600 15.82 A 119794 D Common Stock 2013-12-03 4 S 0 1600 35.9975 D 118194 D Stock Option (Right to Buy) 4.86 2013-12-02 4 M 0 19035 0 D 2015-12-09 Common Stock 19035 0 D Stock Option (Right to Buy) 18.75 2013-12-02 4 M 0 3810 0 D 2018-05-08 Common Stock 3810 0 D Stock Option (Right to Buy) 7.06 2013-12-02 4 M 0 8000 0 D 2019-07-30 Common Stock 8000 0 D Stock Option (Right to Buy) 14.48 2013-12-02 4 M 0 4000 0 D 2020-06-01 Common Stock 4000 0 D Employee Stock Option (Right to Buy) 15.82 2013-12-02 4 M 0 27363 0 D 2021-01-10 Common Stock 27363 122637 D Employee Stock Option (Right to Buy) 15.82 2013-12-03 4 M 0 1600 0 D 2021-01-10 Common Stock 1600 121037 D Includes 33,334 restricted stock units granted on January 10, 2011 which vest on December 31, 2013; 24,000 restricted stock units granted on April 1, 2012 which vest one-third of the total units on April 1, 2014, one-third of the total units on April 1, 2015 and one-third of the total units on April 1, 2016; and 30,000 restricted stock units granted on March 1, 2013 which vest one-quarter of the total units on March 1, 2014, one-quarter of the total units on March 1, 2015, one-quarter of the total units on March 1, 2016 and one-quarter of the total units on March 1, 2017. Vested shares will be delivered to the reporting person as soon as practicable following avesting date. Includes an aggregate of 960 shares acquired under the Insulet Corporation Amended and Restated 2007 Employee Stock Purchase Plan on the following dates: 357 shares acquired on June 29, 2012; 360 shares acquired on December 31, 2012; and 243 shares acquired on June 28, 2013. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2013. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $35.93 to $37.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $35.97 to $36.01. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price. This option is subject to a three-year vesting period, with 50% of the total award vesting one year after the grant date, 25% of the total award vesting two years after the grant date and 25% of the total award vesting three years after the grant date, subject to continued service as a director or consultant. This option is subject to a three-year vesting period with 50% of the total award vesting one year after the grant date, 25% of the total award vesting two years after the grant date and 25% of the total award vesting three years after the grant date, subject to continued service as a director or consultant. This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. /s/ R. Anthony Diehl, attorney in fact 2013-12-03